- ￥2890
- LSM Bio
- 0.31-20NG/ML
- 0.1NG/ML
- 国产
- EF001682
- 2025年07月08日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
50
- 供应商：
LSMBIO
- 检测范围：
0.31-20NG/ML
- 检测方法：
夹心法
- 应用：
夹心法ELISA体外定量检测人血清、血浆或其它相关生物液体中蛋白浓度
- 适应物种：
人
- 标记物：
Hunan ErbB-2
- 样本：
人血清、血浆或其它相关生物液体中天然和重组蛋白
- 灵敏度：
0.1NG/ML
- 规格：
96T
ErbB-2 ELISA KIT|Human
Catalog EF001682
Packing 48T/96T
Reactivity Human
Detect Range 0.312-20ng/ml
ErbB-2 ELISA KIT Sensitivity< 0.188ng/ml
Application ErbB-2 ELISA KIT|Human is for detecting the concentration of Human ErbB-2 in serum, plasma, tissue homogenates and other biological fluids.
Storage condition 6 month at 4 Centigrade
Principle of ErbB-2 ELISA KIT|Human
The microtiter plate provided in ErbB-2 ELISA KIT|Human has been pre-coated with an Human ErbB-2 antibody specific to Human ErbB-2. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated Human ErbB-2antibody preparation specific for Human ErbB-2 then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain Human ErbB-2, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm . The concentration of Human ErbB-2in the samples is then determined by comparing the O.D. of the samples to the standard curve.
*Please noted that ErbB-2 ELISA KIT|Human is only for RUO (Research Use Only), Not for the diagnostic Purpose!
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验RAT/MOUSE GROWTH HORMONE ELISA KIT
实验原理 This assay is a Sandwich ELISA based, sequentially, on: 1) capture of rat or mouse Growth Hormone molecules from samples to the wells of a microtiter plate coated by a pre-titered amount of anti-Growth Hormone
ELISA-Based Quantification of p105 (c-erbB-2, HER2/neu) in Serum of Ovarian Carcinoma
The most important prognostic parameters for gynecologic malignancies are tumor stage, residual tumor after surgical treatment, histological subtype, and degree of malignancy (1-2). However, these factors present an incomplete picture
ERBB4 Mutation Analysis: Emerging Molecular Target for Melanoma Treatment
“hotspot” mutations like BRAFV600 and NRASQ61 or “mini-hotspot” mutations like exon 11 and 13 c-KIT but also heterogeneous somatic mutations dispersed across multiple functionally conserved regions of genes or entire genes. One such example in melanoma
技术资料暂无技术资料 索取技术资料
